Related Experiment Video
Updated: Sep 16, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Online Tailored Decision Aid for Maternal Pertussis Vaccination in a Randomized Controlled Trial: Process Evaluation
Charlotte Anraad1,2, Pepijn van Empelen2, Robert Ac Ruiter1
1Department of Work & Social Psychology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
A web-based decision aid for maternal pertussis vaccination (MPV) showed 79% reach and positive user feedback. However, intervention use, like time spent, needs improvement for greater impact.
Area of Science:
- Public Health
- Health Informatics
- Maternal Health
Background:
- An interactive, web-based decision aid was developed to enhance informed decision-making and maternal pertussis vaccination (MPV) uptake among pregnant individuals.
- Assessing intervention reach, use, and acceptability is crucial for evaluating effectiveness and identifying successful components.
Purpose of the Study:
- To conduct a process evaluation of a web-based decision aid for maternal pertussis vaccination (MPV).
- To evaluate the reach, usage patterns, and user acceptability of the MPV decision aid among pregnant individuals.
Main Methods:
- A randomized controlled trial (RCT) analyzed reach and use of an online decision aid (web app) among pregnant participants recruited via social media and midwifery clinics.
- Reach was measured by website visits; usage data included time spent, clicks, pages visited, and interactive component engagement.
- Acceptability was assessed via a post-intervention survey, with data analyzed descriptively, comparing users and non-users.
Main Results:
- 79% of participants (463/586) accessed the decision aid. Reach was higher for first pregnancies, recruitment via midwives, and higher educational levels.
- Average engagement included 4.25 minutes spent, with most users accessing it once (56.2%) or twice (26.6%).
- Users reported high acceptability (8.0/10), with 38.9% indicating it aided their MPV decision-making.
Conclusions:
- The maternal pertussis vaccination (MPV) decision aid achieved successful reach (79%) and positive user reception.
- While reach and acceptability were strong, intervention use metrics suggest opportunities for enhancing engagement to maximize health benefits.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018